Brief: Scibase Says EIS Technology Primary Endpoint In NIH Study
15/10/2026 09:29
BRIEF-Scibase Says EIS Technology Primary Endpoint In NIH Study Oct 15 (Reuters) - SciBase Holding AB (publ) SCIB.ST:
SCIBASE'S ELECTRICAL IMPEDANCE SPECTROSCOPY (EIS) TECHNOLOGY SELECTED AS PRIMARY ENDPOINT IN NATIONAL INSTITUTE OF HEALTH (NIH) SKIN BARRIER STUDY
Source text: ID:nWkr1STCYt
Further company coverage: SCIB.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))